Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PAK1 | Q13153 | 6/20 | 0.66 |
| ▸ | TERT | O14746 | 12/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.64 |
| ▸ | MAPT | P10636 | 1/20 | 0.64 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3115635 | 0.78 | TERT (1.00) | TERTALDH1A1MAPTMAPK1 | |
| SCHEMBL4300594 | 0.78 | TERT (1.00) | TERTALDH1A1MAPTMAPK1 | |
| SCHEMBL8706439 | 0.78 | TERT (1.00) | TERTALDH1A1MAPTMAPK1 | |
| SCHEMBL8706042 | 0.78 | TERT (1.00) | TERTALDH1A1MAPTMAPK1 | |
| SCHEMBL28461476 | 0.78 | TERT (0.61) | PAK1TERTALDH1A1MAPTMAPK1 | |
| SCHEMBL8527905 | 0.78 | PAK1 (0.79) | PAK1TERTMAPK1 | |
| SCHEMBL8704683 | 0.77 | TERT (1.00) | TERTALDH1A1MAPTMAPK1 | |
| SCHEMBL4298492 | 0.77 | TERT (1.00) | TERTALDH1A1MAPTMAPK1 | |
| SCHEMBL8585967 | 0.76 | PAK1 (0.70) | PAK1MAPK1 | |
| SCHEMBL8585959 | 0.76 | PAK1 (0.70) | PAK1MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260070905-A1 | Derivatives of Imidazo[1,2-A]Pyridine with Anti-Inflammatory Activity | UNIV DE VELENCIA (ES) | 2026-03-12 | — | — | US | claimed |
| US-20260070905-A1 | Derivatives of Imidazo[1,2-A]Pyridine with Anti-Inflammatory Activity | UNIV DE VELENCIA (ES) | 2026-03-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260070905-A1 | Derivatives of Imidazo[1,2-A]Pyridine with Anti-Inflammatory Activity | IL1A, IL6, IL1B | PAK1 4173/4885TERT 2869/4885ALDH1A1 246/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.